Clinical Trial Results:
A randomized, double-blind, double-dummy, parallel group trial comparing 12 weeks treatment with tiotropium inhalation capsules 18 mcg via the HandiHaler® once daily to Combivent® Inhalation Aerosol CFC MDI 2 actuations q.i.d. in COPD patients currently prescribed Combivent® Inhalation Aerosol CFC MDI
Summary
|
|
EudraCT number |
2006-000822-30 |
Trial protocol |
SK LT GB |
Global completion date |
08 Oct 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
16 May 2016
|
First version publication date |
09 May 2015
|
Other versions |
|
Summary report(s) |
205.346 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.